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If you are not a clone, you can be
confident that the first instant of
your life was initiated by a cell
fusion: fertilization [1]. Cell fusion
also serves to assemble and
maintain many of our organs,
including muscles, bones and
placentas [2–5]. Recent attention
has been drawn to cell fusion as a
process that can promote
differentiation of stem cells: bone-
marrow stem cells can differentiate
into several distinct cell types,
including hepatocytes, cardiocytes
and neurons, as a result of cell–cell
fusion [6]. Cell fusion has also been
implicated in the progression of
cancer, causing tumor cells to
become more malignant or
resistant to therapeutic agents [7]. 
Our understanding of the
mechanisms by which two
apposed lipid bilayers fuse has
come from extensive analysis of
intracellular vesicle fusion and
virus–host cell fusion [8,9].
Conformational changes of
fusogenic SNARE proteins in
intracellular vesicle fusion, and
hemagglutinin in virus–host fusion,
bring two apposing lipid bilayers
into close proximity, causing them
to meld into a single bilayer. In
contrast, the mechanisms
underlying the cell–cell fusions
that occur during development are
poorly understood. Although many
genes required for normal cell
fusion in animals have been
reported [1,3,4,10], none has been
demonstrated to encode a bona
fide fusogen capable of joining the
plasma membranes of two cells. 
Recent findings by Shemer et
al. [11] and del Campo et al. [12]
on the EFF-1 protein, which is
essential for developmental cell
fusion in the nematode
Caenorhabditis elegans [13], have
shown that EFF-1 is sufficient to
activate fusion of cells that
normally never fuse, implicating it
as a possible fusogenic molecule.
Moreover, EFF-1 dynamically
localizes to fusion-fated
membranes prior to, and during,
cell fusion [12], suggesting that
EFF-1 may act directly at the
membrane to promote conjoining
of lipid bilayers during
developmental cell fusion.
Although cell fusion functions in
the formation of organs, the
primary role of developmental cell
fusion remains generally
unknown. Fusion may provide a
mechanism for cells to acquire a
new identity and functional
properties. For example, whereas
transdifferentiation of unfused
bone-marrow stem cells into
different cell types might require
specialized stimuli, such as
cytokines and cell–cell
interactions that direct their
differentiation, bone-marrow stem
cells that undergo fusion could
exploit existing cellular
components present in a fusion
partner to reprogram their identity. 
But fusion-competent cells walk
a tightrope, as inappropriate
fusion can have disastrous
consequences. Fusion creates
polyploid cells, and thereby
instability and chromosome loss,
which can result in tumorigenicity.
In fact, many tumor cell types are
fusogenic, and promiscuous
fusion between tumor cells, or
between tumorigenic and normal
cells, endows the hybrids with
new properties, which can include
higher proliferation rates,
metastasis and resistance to
apoptosis and drugs [7]. Thus, the
fusogenicity of tumor cells can
increase tumor cell diversity,
thereby enhancing their
malignancy.
As with any process that
dramatically affects cellular
function, developmental cell fusion
must be spatiotemporally
regulated. Detailed anatomical and
developmental analyses of
C. elegans have revealed that
about one-third of this nematode’s
somatic cells fuse with other cells
to generate a number of epidermal
and muscle syncytia, providing an
excellent model system for
analyzing the in vivo mechanisms
of cell fusion [4,14,15]. This pattern
of cell fusions is highly invariant,
and even the particular side of a
cell that undergoes fusion is highly
reproducible. 
Extensive genetic screens in
C. elegans have identified many
alleles of a single gene, eff-1, that
is essential for epithelial cell
fusions [5,12,13]. In eff-1 mutants,
all epidermal cells fail to fuse. The
eff-1 gene encodes a
association of ATR protein with mouse
meiotic chromosomes cores.
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Cell Fusion: EFF Is Enough
Developmentally programmed cell–cell fusion in Caenorhabditis
elegans requires the EFF-1 protein, which is sufficient to cause
normally non-fusing cells to fuse. EFF-1 localizes to fusion-fated
membranes, implicating it as a direct fusogen.
transmembrane protein that
contains a sequence motif similar
to one occurring in proteins known
to promote fusion of lipid bilayers.
Although developmental cell fusion
is regulated at least in part at the
level of eff-1 transcription [13,16], it
is not known whether EFF-1
functions as a fusogen that directly
promotes the mixing of lipid
bilayers, nor how EFF-1 activity is
restricted to particular sets of cells,
such that many adjacent and
distinct syncytia are created.
At which step(s) in cell fusion is
EFF-1 activity required? Shemer et
al. [11] performed ultra-structural
studies of eff-1 mutants and found
that the unfused epithelial cells are
separated by intact plasma
membrane borders. The
separation between these
membranes is indistinguishable
from that between adjacent non-
fusing cells in wild-type animals,
implying that EFF-1 is required for
pre-initiation and/or initiation
stages of epithelial cell fusion. In
addition to epithelial cells,
pharyngeal muscle cells undergo
cell fusion in wild-type animals.
Although most plasma membranes
in muscle cells remain intact in eff-
1 mutants, cell fusion is initiated
and small pores are formed in
some plasma membranes of this
cell type. These small pores,
however, arrest without further
expansion, which would otherwise
complete cell fusion. 
EFF-1 thus appears to be
required for both initiation of cell
fusion and for expansion of fusion
pores in pharyngeal muscle cells.
These observations also suggest
that fusion and EFF-1 activity are
differentially regulated in two
different cell types. Consistent
with different mechanisms acting
in distinct cell types, EFF-1 is not
at all required for at least two
heterotypic cell fusions: fusion of
the gonadal anchor cell and
uterine cells, and joining of sperm
and oocytes at fertilization. Thus,
it is apparent that, while eff-1 is
required for homotypic cell
fusions in epidermis and muscles,
other molecule(s) function in
heterotypic cell fusions.
Both Shemer et al. [11] and del
Campo et al. [12] demonstrated
that EFF-1 is not only essential,
but is also sufficient to promote
cell fusion: ectopic expression of
EFF-1 causes cells in both
embryos and larvae to fuse
inappropriately. During normal
development, cell–cell fusion is
observed only in differentiated
tissues. While ectopic EFF-1 can
direct inappropriate fusion of
fully differentiated cells,
remarkably, it is also capable of
triggering fusion of
undifferentiated early
blastomeres well before any
fusions normally occur during
embryogenesis; thus, EFF-1
expression is sufficient to
promote both ectopic and
heterochronic cell–cell fusion. 
The fusion events triggered by
ectopic EFF-1 appear similar to
normal fusions: the kinetics of
membrane permeability, estimated
by the diffusion rate of cytoplasmic
GFP in fusing cells, reveal that
ectopic EFF-1 induces small pores
with permeability similar to that
observed during normal membrane
fusion. These observations
suggest that cell fusion may be
directly induced by the fusogenic
action of EFF-1, rather than as a
consequence of EFF-1-mediated
activation of unknown fusogenic
component(s). Interestingly,
overexpression of EFF-1 in eff-1
mutants revealed that restoration
of fusion between cells normally
fated to fuse during development
precedes the ectopic fusion
between cells that normally do not
fuse; these observations suggest
that the fusogenic action of EFF-1
may be enhanced by other
component(s) that predispose
epidermal cells to fusion.
How does a fusion-fated cell
find its appropriate partner among
several choices of surrounding
cells and achieve specific cell
fusion? The specificity of cell
fusion is regulated, at least in part,
by transcriptional control of eff-1
expression [13,16]. But eff-1 also
appears to be post-
transcriptionally regulated, as the
gene is expressed in some cells
that never fuse during normal
development. Inappropriate cell
fusion appears to be prevented in
part by inter-tissue barriers, in
particular basal laminae. 
Our recent findings [17] also
indicate that components of the
vacuolar ATPase prevent
widespread cell fusion, perhaps
by functioning at the plasma
membrane to restrict EFF-1
action. Moreover, del Campo et al.
[11] suggest that EFF-1
localization plays a key role in the
specificity of cell fusion. The
restriction of fusion to particular
sets of cells apparently involves
redistribution of EFF-1 to the
boundary of cells fated to fuse:
analysis of an EFF-1::GFP reporter
protein revealed that it
concentrates to cell–cell contacts
between fusion-fated epidermal
cells. Given that cell fusion
Dispatch    
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Figure 1. Model for EFF-1-
mediated cell fusion in C.
elegans.
(A) Cell fusion in wild-type
animals. Homotypic interac-
tions between EFF-1 on
juxtaposed plasma mem-
branes of fusion-fated cells
bring the two membranes
into close proximity, facili-
tating the mixing of lipid
bilayers and catalyzing cell
fusion. (B,C) Accumulation
of GFP fluorescence in
adjacent membranes of
fusion-fated cells express-
ing EFF-1::GFP. Strong GFP
signal can be seen at the
boundary of apposed mem-
branes of fusing cells when
both express high levels of EFF-1::GFP. (B) Only a very weak GFP signal is seen at the
boundary between a cell expressing a high level of EFF-1::GFP and its fusion partner
that expresses only the low endogenous levels of EFF-1. (C) These findings suggest
that the accumulation of EFF-1 at the boundary of fusion-fated cells depends on stoi-
chiometric trans interactions between EFF-1 molecules in each of the membranes des-
tined to fuse. Model adapted from del Campo et al. [12].
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initiates at a site along the apical
edge of the fusing border, and
that EFF-1::GFP also accumulates
along the apical edge of the cell
boundary, prior to fusion, it is
likely that accumulation of EFF-1
at this boundary is a critical step
in the initiation of fusion.
Analysis of the dynamics of EFF-
1::GFP localization revealed two
modes by which it accumulates at
cell boundaries. In some cases, for
example in epidermal cells that
migrate toward each other and
meet at the ventral midline, the
protein is first expressed and
present intracellularly; it then
moves to the membrane and
accumulates at the boundary after
the cells have contacted each
other. In other examples, such as
with two adjacent dorsal epidermal
cells, EFF-1::GFP appears at pre-
existing cell–cell contacts,
concomitant with the onset of its
expression. The amount of EFF-
1::GFP accumulating at cell
boundaries exceeds the sum of the
amount present in each membrane
of the two adjacent cells before the
boundary accumulation is
observed, suggesting that the
protein is actively transported
specifically to cell boundaries,
and/or that its endocytosis is
inhibited in that region.
Interestingly, accumulation of EFF-
1::GFP at the cell boundaries is not
observed in cells containing high
levels of the protein (‘bright’ cells)
at the boundary with cells that do
not express the reporter protein
(‘dark’ cells), even when the
bright–dark pair undergoes fusion.
del Campo et al. [12] suggest
that accumulation of EFF-1 at the
boundary between cells destined
to fuse is achieved by
stoichiometric trans-interaction
between EFF-1 molecules on
juxtaposed membranes (Figure 1).
Such trans-interactions of EFF-1
molecules may facilitate
membrane fusion by bringing the
membranes into close proximity,
in a manner analogous to SNARE-
mediated fusion of vesicles and
target membranes.
The extracellular domain of EFF-
1 contains two sequence motifs
that might be involved in lipid
bilayer fusion: a phospholipase A2
(PLA2) active site consensus, and
a short hydrophobic stretch similar
to a viral fusion peptide. Analysis
of variant EFF-1 forms carrying
point mutations in the putative
PLA2 active site domain that are
analogous to mutations known to
abolish the enzymatic activity of
PLA2 indicated that this region is
not essential for EFF-1 function. In
contrast, deletion of the
hydrophobic fusion peptide-like
region eliminates the fusogenic
activity of EFF-1 [12]. These latter
mutants fail to localize to the
boundary of normally fusing cells,
suggesting that the potential
fusogenic activity of this fusion
peptide domain may be intimately
coupled to movement of the
protein to the boundary between
fusion-fated membranes. Further
structure–function analyses of
EFF-1, combined with in vitro
reconstitution of membrane fusion
in a liposome fusion reaction,
should help to reveal the
molecular mechanism underlying
fusion of juxtaposed plasma
membranes and make it possible
to assess whether EFF-1 is a
genuine fusogen that is capable of
acting alone to induce membrane
fusion.
Much of our mechanistic
understanding of intracellular
membrane fusion in the eukaryotic
secretory pathway derived from
genetic studies in yeast, combined
with in vitro reconstitution assays
[9,18]. Similarly, genetic analyses
in animals have begun to uncover
the key components of the
molecular machinery for cell–cell
fusion [4,19]. It will be of great
interest to understand how EFF-1,
a key fusogenic regulatory
molecule, is restricted in its action
to particular cell partners, and to
what degree the molecular details
of extracellular membrane fusion
are related to those underlying
intracellular fusion of lipid bilayers.
Moreover, access to the
molecules that mediate cell–cell
fusion may prove instrumental in
developing methods for clinically
intervening in processes as
disparate as fertility,
tumorigenesis and stem cell
differentiation. The ability to direct
fusion of cells at will by expressing
fusogenic molecules such as EFF-
1 represents a substantial first
step toward manipulating this
critical cellular process.
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